PATIENT‐REPORTED EXPERIENCE AND PREFERENCES WITH TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) AND FOLLICULAR LYMPHOMA (FL)
Sign Up to like & getrecommendations! Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.225_2631
Abstract: There is no connection between an RTI employee's compensation and the projects on which they work. Information about projects with other clients is confidential. Comenencia-Ortíz, E: Employment Leadership Position: Roche, Genentech; Stock Ownership: Roche, Genentech;… read more here.
Keywords: time; treatment; lymphoma; genentech ... See more keywords
Chair-Time During Polishing with Different Burs and Drills After Cement Customized Brackets Bonding: An In Vitro Comparative Study
Sign Up to like & getrecommendations! Published in 2025 at "Dentistry Journal"
DOI: 10.3390/dj13080347
Abstract: Introduction: Digital planning and evolution of technology is allowing dentistry to be more efficient in time than before. In orthodontics the main purpose is to obtain fewer patient visits and to reduce the bonding time.… read more here.
Keywords: time; different burs; chair time; bur ... See more keywords
Real-World Assessment of Patient Care and Practice Efficiency With the Introduction of Subcutaneous Rituximab.
Sign Up to like & getrecommendations! Published in 2021 at "Oncology"
DOI: 10.46883/2021.25920935
Abstract: INTRODUCTION: A subcutaneous (SC) formulation of the anti-CD20 monoclonal antibody, rituximab (Rituxan), is approved in diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and chronic lymphocytic leukemia (CLL). Rituximab-SC (R-SC) has been associated with time… read more here.
Keywords: time; care; adoption; chair time ... See more keywords